Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a high-risk pharmaceutical company based in China. Specializing in the manufacturing and sale of traditional Chinese medicine, western medicine, and healthcare products, the company operates in two main segments focusing on Chinese Medicine and Western Medicine. With an ESG score of 34.4, Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd generates the bulk of its revenue from the sale of Chinese pharmaceutical products.